Foley Attorneys Publish on Telemedicine Considerations for Decentralized Clinical Trials
January 14, 2025
Applied Clinical Trials
Foley & Lardner LLP attorneys Jessica Warwick, Kyle Faget, and Monica Chmielewski authored the Applied Clinical Trials article, “Telemedicine Considerations When Conducting Decentralized Clinical Trials.”
“Decentralized clinical trials (DCTs) involve some or all trial-related activities conducted at locations other than traditional clinical trial sites, such as via telemedicine or in a clinical trial participant’s home,” the authors write. “The use of telemedicine in DCTs implicates various state legal and regulatory considerations as the performance of research, or the performance of certain procedures within a clinical trial, may and often fall within and are deemed to be the ‘practice of medicine.'”
Related News
August 21, 2026
In the News
Betsy Stone Discusses Federal EPR Challenges and Producer Implications
Foley & Lardner LLP senior counsel Betsy Stone shared insights in the Packaging Dive article, “California EPR lawsuit escalates as forthcoming Oregon ruling looms,” analyzing ongoing federal court challenges to extended producer responsibility (EPR) laws.
August 18, 2026
In the News
Lynn Gandhi Shares Insights on Recent State Tax Developments
Foley & Lardner LLP partner Lynn Gandhi was featured in a recent Law360 article analyzing a Massachusetts Appellate Tax Board decision upholding Interstate Income Act (P.L. 86-272) protections for certain entities in a combined reporting group.
August 17, 2026
In the News
Louis Lehot Weighs in on Acceleration of Software Industry M&A
Foley & Lardner LLP partner Louis Lehot shared perspective on the acceleration of software industry consolidation in the Law360 article, "$1.3B Airtable Deal Highlights Software M&A Revival."